<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Balaxi Pharmaceuticals Limited — News on 6ix</title>
    <link>https://6ix.com/company/balaxi-pharmaceuticals-limited</link>
    <description>Latest news and press releases for Balaxi Pharmaceuticals Limited on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 01 Feb 2023 20:52:22 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/balaxi-pharmaceuticals-limited" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836499778dffbe2df152945.webp</url>
      <title>Balaxi Pharmaceuticals Limited</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited</link>
    </image>
    <item>
      <title>Press Release Feb 01 2023</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-feb-01-2023-13</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-feb-01-2023-13</guid>
      <pubDate>Wed, 01 Feb 2023 20:52:22 GMT</pubDate>
      <description>BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated 0 , , titled &quot;Balaxi Pharmaceuticals growth remains robust on back of geographical expansions&quot;.</description>
    </item>
    <item>
      <title>Press Release Dec 13 2022</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-dec-13-2022-4</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-dec-13-2022-4</guid>
      <pubDate>Tue, 13 Dec 2022 17:33:07 GMT</pubDate>
      <description>BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about press release dated 13-Dec-2022 titled Balaxi Pharmaceuticals Limited conducts groundbreaking ceremony for its upcoming ��� 85 Cr. State-of-the-Art Manufacturing Facility in Hyderabad</description>
    </item>
    <item>
      <title>Press Release Nov 05 2022</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-nov-05-2022-6</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-nov-05-2022-6</guid>
      <pubDate>Sat, 05 Nov 2022 19:18:10 GMT</pubDate>
      <description>BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about press release dated 05-Nov-2022 titled Balaxi Pharmaceuticals delivers strong growth in Q2 FY23</description>
    </item>
    <item>
      <title>Press Release Sep 06 2022</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-sep-06-2022-9</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-sep-06-2022-9</guid>
      <pubDate>Tue, 06 Sep 2022 04:46:57 GMT</pubDate>
      <description>BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about press release dated 06-Sep-2022 titled Balaxi Pharma to Issue Equity Shares/Warrants aggregating to INR 49.61 crore on Preferential Basis</description>
    </item>
    <item>
      <title>Press Release Aug 02 2022</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-aug-02-2022-19</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-aug-02-2022-19</guid>
      <pubDate>Tue, 02 Aug 2022 18:21:55 GMT</pubDate>
      <description>BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about press release dated 02-Aug-2022 titled Balaxi Pharmaceuticals reports continued solid growth in Q1 FY23</description>
    </item>
    <item>
      <title>Press Release May 23 2022</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-may-23-2022-10</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-may-23-2022-10</guid>
      <pubDate>Tue, 24 May 2022 00:13:16 GMT</pubDate>
      <description>BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about press release dated 23-May-2022 titled Balaxi Pharmaceuticals reports continued solid growth in Q4 and FY22���</description>
    </item>
    <item>
      <title>Press Release Feb 10 2022</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-feb-10-2022-30</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-feb-10-2022-30</guid>
      <pubDate>Thu, 10 Feb 2022 17:56:36 GMT</pubDate>
      <description>BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated February 10, 2022, titled &quot;Balaxi Pharmaceuticals reports continuedsolid growth in Q3FY22&quot;.</description>
    </item>
    <item>
      <title>Press Release Oct 29 2021</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-oct-29-2021-21</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-oct-29-2021-21</guid>
      <pubDate>Fri, 29 Oct 2021 21:03:54 GMT</pubDate>
      <description>BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated October 29, 2021, titled &quot;Balaxi Pharmaceuticals reports 19% PAT growth YoY for Q2FY22, lays down strategy of backward integration to have a sustainable growth in frontiermarkets&quot;.</description>
    </item>
    <item>
      <title>Press Release Oct 28 2021</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-oct-28-2021-28</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-oct-28-2021-28</guid>
      <pubDate>Thu, 28 Oct 2021 13:44:14 GMT</pubDate>
      <description>BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated October 28, 2021, titled &quot;BALAXI commits to backward integration for manufacturing new market-specific differentiated formulations that will serve to expand its portfolio of newly developed, proprietary, and niche branded formulations&quot;.</description>
    </item>
    <item>
      <title>Press Release Jul 19 2021</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-jul-19-2021-9</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-jul-19-2021-9</guid>
      <pubDate>Mon, 19 Jul 2021 23:09:52 GMT</pubDate>
      <description>BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated July 19, 2021, titled &quot;Balaxi Pharmaceuticals further diversifies geographical mix, reports 23% YoY increase in Profit After Tax for Q1FY22&quot;.</description>
    </item>
    <item>
      <title>Press Release May 21 2021</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-may-21-2021-7</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-may-21-2021-7</guid>
      <pubDate>Fri, 21 May 2021 22:53:16 GMT</pubDate>
      <description>BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated May 21, 2021, titled &quot;Balaxi Pharmaceuticals reports a PAT of INR 381 million for FY21; further strengthens the Product Pipeline &quot;.</description>
    </item>
    <item>
      <title>Press Release (Revised) Jan 20 2021</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-revised-jan-20-2021</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-revised-jan-20-2021</guid>
      <pubDate>Wed, 20 Jan 2021 14:29:55 GMT</pubDate>
      <description>BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a revised press release dated January 19, 2021, titled &quot;Balaxi Pharmaceuticals reports Revenue of INR 1,784 million for 9M FY21&quot;.</description>
    </item>
    <item>
      <title>Press Release Jan 19 2021</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-jan-19-2021-6</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-jan-19-2021-6</guid>
      <pubDate>Wed, 20 Jan 2021 00:13:55 GMT</pubDate>
      <description>BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated January 19, 2021, titled &quot;Balaxi Pharmaceuticals reports Revenue of INR 1,784 million for 9M FY21&quot;.</description>
    </item>
    <item>
      <title>Press Release Oct 12 2020</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-oct-12-2020-7</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-oct-12-2020-7</guid>
      <pubDate>Mon, 12 Oct 2020 19:49:28 GMT</pubDate>
      <description>Balaxi Ventures Limited has informed the Exchange regarding a press release dated October 12, 2020, titled &quot;Balaxi Pharmaceuticals reports revenue of INR 1,124 million in H1FY21&quot;.</description>
    </item>
    <item>
      <title>Press Release Oct 07 2020</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-oct-07-2020-9</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-oct-07-2020-9</guid>
      <pubDate>Wed, 07 Oct 2020 18:52:46 GMT</pubDate>
      <description>Balaxi Ventures Limited has informed the Exchange regarding a press release dated October 07, 2020, titled &quot;Balaxi Ventures Limited renamed as Balaxi Pharmaceuticals Limited&quot;.</description>
    </item>
    <item>
      <title>Press Release Sep 11 2020</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-sep-11-2020-7</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-sep-11-2020-7</guid>
      <pubDate>Fri, 11 Sep 2020 13:57:56 GMT</pubDate>
      <description>Balaxi Ventures Limited has informed the Exchange regarding a press release dated September 11, 2020, titled &quot;BALAXI VENTURES ENTERS FINAL LEG OF GROUP BUSINESS CONSOLIDATION AND OUTLINES PLAN TO ENTER CENTRAL AFRICAN REPUBLIC&quot;.</description>
    </item>
    <item>
      <title>Press Release Aug 27 2020</title>
      <link>https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-aug-27-2020-16</link>
      <guid isPermaLink="true">https://6ix.com/company/balaxi-pharmaceuticals-limited/news/press-release-aug-27-2020-16</guid>
      <pubDate>Thu, 27 Aug 2020 21:21:22 GMT</pubDate>
      <description>Balaxi Ventures Limited has informed the Exchange regarding a press release dated August 27, 2020, titled &quot;BALAXI VENTURES LIMITED ANNOUNCES ACQUISITION OF 49% STAKE IN GROUP S ANGOLA BASED DISTRIBUTION ARM&quot;.</description>
    </item>
  </channel>
</rss>